BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8881366)

  • 1. The last revised "Euro-American classification" of lymphoid leukemias and non-Hodgkin's lymphomas: the same inaccuracies and inconsistencies in a chaotic complexity.
    Mathé G
    Biomed Pharmacother; 1996; 50(3-4):97-117. PubMed ID: 8881366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoid leukemia and non-Hodgkin's lymphoma type continuum, superimposed to lymphocyte differentiation step continuum. A proposition for a revised W. H. O. lympiioid leukemia-lymphoma categorisation.
    Mathé G
    Biomed Pharmacother; 1985; 39(3):109-14. PubMed ID: 3864494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in the classification of lymphoid and/or monocytoid leukemias and of lympho and reticulosarcomas (non-Hodgkin's lymphomas).
    Mathé G; Belpomme D; Dantchev D; Pouillart P
    Biomedicine; 1975 May; 22(3):177-85. PubMed ID: 809067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
    Meusers P; Brittinger G
    Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent progress made in the classification of lymphoid and monocytoid leukemias and of lympho- and reticulo-sarcomas].
    Mathe G; Belpomme D; Dantchev D; Pouillart P
    Ann Med Interne (Paris); 1975; 126(8-9):523-34. PubMed ID: 766687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lymphoid leukemias: recent advances in biology and therapy.
    Foon KA
    Stem Cells; 1995 Jan; 13(1):1-21. PubMed ID: 7719244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histopathology of leukaemic non-Hodgkin's lymphoma in bone marrow].
    Buhr T; Länger F; Schlué J; V Wasielewski R; Kreipe H
    Pathologe; 2002 Nov; 23(6):438-47. PubMed ID: 12436297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New REAL clinical entities.
    Fisher RI; Miller TP; Grogan TM
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S5-12. PubMed ID: 9672769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation.
    Felgar RE; Macon WR; Kinney MC; Roberts S; Pasha T; Salhany KE
    Am J Pathol; 1997 Jun; 150(6):1893-900. PubMed ID: 9176382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
    LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
    Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas ligand expression in nodal non-Hodgkin's lymphoma.
    Müllauer L; Mosberger I; Chott A
    Mod Pathol; 1998 Apr; 11(4):369-75. PubMed ID: 9578088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prolymphocytic-lymphocytic leukemization of B-cell lymphosarcomas].
    Osmanov DSh; Kruglova GV; Frenkel' MA; Tupitsin NN; Probatova NA; Kondrat'eva TT; Sholokhova EN; Finogenova IA; Dvoretskiĭ VV
    Ter Arkh; 1996; 68(7):42-8. PubMed ID: 8928071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical typing of non-Hodgkin's lymphoma-comparing working formulation and WHO classification.
    Kalyan K; Basu D; Soundararaghavan J
    Indian J Pathol Microbiol; 2006 Apr; 49(2):203-7. PubMed ID: 16933715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.
    Ko YH; Kim CW; Park CS; Jang HK; Lee SS; Kim SH; Ree HJ; Lee JD; Kim SW; Huh JR
    Cancer; 1998 Aug; 83(4):806-12. PubMed ID: 9708949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
    Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
    J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The common acute lymphoid leukemia antigen on b cells of chronic lymphoid leukemia and non-Hodgkin's lymphoma.
    Canon C; Augier C; Reizenstein P; Goutner A; de Vassal F; Mathé G
    Biomed Pharmacother; 1983; 37(2):90-2. PubMed ID: 6604552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Hodgkin's lymphoproliferative disorders involving the spleen.
    Arber DA; Rappaport H; Weiss LM
    Mod Pathol; 1997 Jan; 10(1):18-32. PubMed ID: 9021723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological and clinical differences between lymphoblastic leukemia and lymphoma originating from non-T, non-B cells, T cells and B cells].
    Rupniewska ZM; Kniaź M
    Postepy Hig Med Dosw; 1980; 34(2):119-41. PubMed ID: 7017639
    [No Abstract]   [Full Text] [Related]  

  • 20. [The results of histological and immunohistological studies of primary biopsies in 400 patients with non-Hodgkin's lymphoma in the North-West region of Russia (according to WHO classification)].
    Krivolapov IuA
    Ter Arkh; 2004; 76(7):64-70. PubMed ID: 15379131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.